Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Boosts FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Bristol-Myers Squibb (BMY) PT Raised to $80 at UBS
April 29, 2016 8:16 AM EDTUBS analyst Marc Goodman reiterated a Buy rating and boosted his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $80.00 (from $73.00) following results.
Goodman highlighted:
"Regarding Opdivo, mgt indicated that (1) it has >80% dollar share in US PD-1 category, and comparable shares in... More
